{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:30:28Z","timestamp":1768426228983,"version":"3.49.0"},"reference-count":59,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Michael J. Fox Foundation [RRIA 2014 (Rapid Response Innovation Awards) Program","award":["10189"],"award-info":[{"award-number":["10189"]}]},{"name":"Michael J. Fox Foundation [RRIA 2014 (Rapid Response Innovation Awards) Program","award":["PI14\/00679"],"award-info":[{"award-number":["PI14\/00679"]}]},{"name":"Michael J. Fox Foundation [RRIA 2014 (Rapid Response Innovation Awards) Program","award":["JR15\/00008"],"award-info":[{"award-number":["JR15\/00008"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["10189"],"award-info":[{"award-number":["10189"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00679"],"award-info":[{"award-number":["PI14\/00679"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["JR15\/00008"],"award-info":[{"award-number":["JR15\/00008"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Juan Rodes grant \u201cJR15\/00008\u201d (IG) (Co-funded by European Regional Development Fund\/European Social Fund-\u201cInvesting in your future\u201d)","award":["10189"],"award-info":[{"award-number":["10189"]}]},{"name":"Juan Rodes grant \u201cJR15\/00008\u201d (IG) (Co-funded by European Regional Development Fund\/European Social Fund-\u201cInvesting in your future\u201d)","award":["PI14\/00679"],"award-info":[{"award-number":["PI14\/00679"]}]},{"name":"Juan Rodes grant \u201cJR15\/00008\u201d (IG) (Co-funded by European Regional Development Fund\/European Social Fund-\u201cInvesting in your future\u201d)","award":["JR15\/00008"],"award-info":[{"award-number":["JR15\/00008"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background: We aimed to characterize subtypes of synucleinopathies using a clustering approach based on cognitive and other nonmotor data and to explore structural and functional magnetic resonance imaging (MRI) brain differences between identified clusters. Methods: Sixty-two patients (n = 6 E46K-SNCA, n = 8 dementia with Lewy bodies (DLB) and n = 48 idiopathic Parkinson\u2019s disease (PD)) and 37 normal controls underwent nonmotor evaluation with extensive cognitive assessment. Hierarchical cluster analysis (HCA) was performed on patients\u2019 samples based on nonmotor variables. T1, diffusion-weighted, and resting-state functional MRI data were acquired. Whole-brain comparisons were performed. Results: HCA revealed two subtypes, the mild subtype (n = 29) and the severe subtype (n = 33). The mild subtype patients were slightly impaired in some nonmotor domains (fatigue, depression, olfaction, and orthostatic hypotension) with no detectable cognitive impairment; the severe subtype patients (PD patients, all DLB, and the symptomatic E46K-SNCA carriers) were severely impaired in motor and nonmotor domains with marked cognitive, visual and bradykinesia alterations. Multimodal MRI analyses suggested that the severe subtype exhibits widespread brain alterations in both structure and function, whereas the mild subtype shows relatively mild disruptions in occipital brain structure and function. Conclusions: These findings support the potential value of incorporating an extensive nonmotor evaluation to characterize specific clinical patterns and brain degeneration patterns of synucleinopathies.<\/jats:p>","DOI":"10.3390\/biomedicines11020573","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T02:28:27Z","timestamp":1676514507000},"page":"573","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Brain Degeneration in Synucleinopathies Based on Analysis of Cognition and Other Nonmotor Features: A Multimodal Imaging Study"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7715-3764","authenticated-orcid":false,"given":"Olaia","family":"Lucas-Jim\u00e9nez","sequence":"first","affiliation":[{"name":"Department of Psychology, Faculty of Health Sciences, University of Deusto, 48007 Bilbao, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2434-5252","authenticated-orcid":false,"given":"Naroa","family":"Ibarretxe-Bilbao","sequence":"additional","affiliation":[{"name":"Department of Psychology, Faculty of Health Sciences, University of Deusto, 48007 Bilbao, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibai","family":"Diez","sequence":"additional","affiliation":[{"name":"Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114-1107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Pe\u00f1a","sequence":"additional","affiliation":[{"name":"Department of Psychology, Faculty of Health Sciences, University of Deusto, 48007 Bilbao, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Tijero","sequence":"additional","affiliation":[{"name":"Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain"},{"name":"Department of Neurology, Cruces University Hospital, 48903 Barakaldo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Gald\u00f3s","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Cruces University Hospital, 48903 Barakaldo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9808-6943","authenticated-orcid":false,"given":"Ane","family":"Murueta-Goyena","sequence":"additional","affiliation":[{"name":"Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain"},{"name":"Department of Neurosciences, University of the Basque Country (UPV\/EHU), 48940 Leioa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-4757","authenticated-orcid":false,"given":"Roc\u00edo","family":"Del Pino","sequence":"additional","affiliation":[{"name":"Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Acera","sequence":"additional","affiliation":[{"name":"Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"G\u00f3mez-Esteban","sequence":"additional","affiliation":[{"name":"Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain"},{"name":"Department of Neurology, Cruces University Hospital, 48903 Barakaldo, Spain"},{"name":"Department of Neurosciences, University of the Basque Country (UPV\/EHU), 48940 Leioa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6045-2840","authenticated-orcid":false,"given":"I\u00f1igo","family":"Gabilondo","sequence":"additional","affiliation":[{"name":"Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain"},{"name":"Department of Neurology, Cruces University Hospital, 48903 Barakaldo, Spain"},{"name":"IKERBASQUE, The Basque Foundation for Science, 48009 Bilbao, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0952-0649","authenticated-orcid":false,"given":"Natalia","family":"Ojeda","sequence":"additional","affiliation":[{"name":"Department of Psychology, Faculty of Health Sciences, University of Deusto, 48007 Bilbao, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/01.wnl.0000338632.00552.cb","article-title":"Cognitive impairment in incident, untreated parkinson disease: The norwegian parkwest study","volume":"72","author":"Aarsland","year":"2009","journal-title":"Neurology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1212\/01.wnl.0000180516.69442.95","article-title":"Cognitive profile of patients with newly diagnosed Parkinson\u2019s disease","volume":"65","author":"Post","year":"2005","journal-title":"Neurology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0b013e3181f39d0e","article-title":"Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis","volume":"75","author":"Aarsland","year":"2010","journal-title":"Neurology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diangostic Criteria for Mild Cognitive Impairment in Parkinson\u2019s disease:Movement Disorder Society Task Force Guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney Multicenter Study of Parkinson\u2019s disease: The inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/PL00007856","article-title":"The heterogeneity of idiopathic Parkinson\u2019s disease","volume":"249","author":"Foltynie","year":"2002","journal-title":"J. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/mds.23116","article-title":"The identification of Parkinson\u2019s disease subtypes using cluster analysis: A systematic review","volume":"25","author":"Heiser","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.parkreldis.2016.04.026","article-title":"Clinical clusters and dopa-minergic dysfunction in de-novo Parkinson disease","volume":"28","author":"Erro","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/jnnp-2018-318337","article-title":"Developing and validating Parkinson\u2019s disease subtypes and their motor and cognitive progression","volume":"89","author":"Lawton","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/acn3.51102","article-title":"Parkinson disease clinical subtypes: Key features & clinical milestones","volume":"7","author":"Campbell","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","article-title":"New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression","volume":"72","author":"Fereshtehnejad","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parkreldis.2018.02.006","article-title":"Parkinsonism and Related Disorders Cortical atrophy patterns in early Parkinson\u2019s disease patients using hierarchical cluster analysis","volume":"50","author":"Uribe","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.parkreldis.2020.11.010","article-title":"Parkinsonism and Related Disorders Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson\u2019s disease","volume":"82","author":"Inguanzo","year":"2021","journal-title":"Park. Relat. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Cigdem, O., Demirel, H., and Unay, D. (2019, January 6\u20139). The Performance of Local-Learning Based Clustering Feature Selection Method on the Diagnosis of Parkinson\u2019s Disease Using Structural MRI. Proceedings of the 2019 IEEE International Conference on Systems, Man and Cybernetics (SMC), Bari, Italy.","DOI":"10.1109\/SMC.2019.8914611"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"102111","DOI":"10.1016\/j.nicl.2019.102111","article-title":"Predicting severity and prognosis in Parkinson\u2019s disease from brain microstructure and connectivity","volume":"25","author":"Abbasi","year":"2019","journal-title":"NeuroImage Clin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1002\/hbm.25110","article-title":"Clinically relevant connectivity features define three subtypes of Parkinson\u2019s disease patients","volume":"41","author":"Guo","year":"2020","journal-title":"Hum. Brain Mapp."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1017\/S1041610213001488","article-title":"Covariant perfusion patterns provide clues to the origin of cognitive fluctuations and attentional dysfunction in Dementia with Lewy bodies","volume":"25","author":"Taylor","year":"2013","journal-title":"Int. Psychogeriatr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2011.07.047","article-title":"Initial neuropsychological impairments in patients with the E46K mutation of the \u03b1-synuclein gene (PARK 1)","volume":"310","author":"Somme","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11065-008-9055-0","article-title":"Neuropsychological Characteristics of Dementia with Lewy Bodies and Parkinson\u2019s Disease with Dementia: Differentiation, Early Detection, and Implications for \u201cMild Cognitive Impairment\u201d and Biomarkers","volume":"18","year":"2008","journal-title":"Neuropsychol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.nicl.2014.03.013","article-title":"NeuroImage: Clinical fMRI resting state networks and their association with cognitive fluctuations in dementia with Lewy bodies","volume":"4","author":"Peraza","year":"2014","journal-title":"NeuroImage Clin."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1159\/000441184","article-title":"Clinical and Cognitive Phenotype of Mild Cognitive Impairment Evolving to Dementia with Lewy Bodies","volume":"5","author":"Cagnin","year":"2015","journal-title":"Dement. Geriatr. Cogn. Disord. Extra"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ana.25944","article-title":"Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease","volume":"89","author":"Arana","year":"2021","journal-title":"Ann. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00415-020-09783-7","article-title":"Autonomic dysfunction is associated with neuropsychological impairment in Lewy body disease","volume":"267","author":"Acera","year":"2020","journal-title":"J. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/brain\/awm184","article-title":"Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia","volume":"130","author":"Douaud","year":"2007","journal-title":"Brain"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","article-title":"Advances in functional and structural MR image analysis and implementation as FSL","volume":"23","author":"Smith","year":"2004","journal-title":"Neuroimage"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/nbm.1543","article-title":"Twenty-five pitfalls in the analysis of diffusion MRI data","volume":"23","author":"Jones","year":"2010","journal-title":"NMR Biomed."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.neuroimage.2009.05.005","article-title":"Correlations and anticorrelations in resting-state functional connectivity MRI: A quantitative comparison of preprocessing strategies","volume":"47","author":"Weissenbacher","year":"2009","journal-title":"Neuroimage"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/brain.2012.0073","article-title":"A Functional Connectivity Toolbox for Correlated and Anticorrelated Brain Networks","volume":"2","year":"2012","journal-title":"Brain Connect."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ana.10078","article-title":"Dopaminergic modulation of cortical function in patients with Parkinson\u2019s disease","volume":"51","author":"Mattay","year":"2002","journal-title":"Ann. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mds.28321","article-title":"The Pathophysiological Correlates of Parkinson\u2019s Disease Clinical Subtypes","volume":"36","author":"Belvisi","year":"2021","journal-title":"Mov. Disord."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Yang, H.J., Kim, Y.E., Yun, J.Y., Kim, H.J., and Jeon, B.S. (2014). Identifying the clusters within nonmotor manifestations in early Parkinson\u2019s disease by using unsupervised cluster analysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091906"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fnagi.2017.00301","article-title":"Parkinson\u2019s disease subtypes identified from cluster analysis of motor and non-motor symptoms","volume":"9","author":"Mu","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref_35","first-page":"17013","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mds.26077","article-title":"The Onset of Nonmotor Symptoms in Parkinson\u2019s disease (The ONSET PDStudy)","volume":"30","author":"Hotter","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/brain\/awx118","article-title":"Clinical criteria for subtyping Parkinson\u2019s disease: Biomarkers and longitudinal progression","volume":"140","author":"Fereshtehnejad","year":"2017","journal-title":"Brain"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"100060","DOI":"10.1016\/j.bbih.2020.100060","article-title":"Brain, Behavior, & Immunity\u2014Health Lipopolysaccharide animal models of Parkinson\u2019s disease: Recent progress and relevance to clinical disease","volume":"4","author":"Deng","year":"2020","journal-title":"Brain Behav. Immun. Health"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","article-title":"Where does Parkinson disease pathology begin in the brain?","volume":"61","author":"Bohl","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ana.20160","article-title":"Idiopathic hyposmia as a preclinical sign of Parkinson\u2019s disease","volume":"56","author":"Ponsen","year":"2004","journal-title":"Ann. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1155\/2019\/3753786","article-title":"Hyposmia as a predictive marker of Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"2019","author":"Sui","year":"2019","journal-title":"Biomed Res. Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.27186","article-title":"Neuropathology of autonomic dysfunction in synucleinopathies","volume":"33","author":"Coon","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_44","first-page":"S53","article-title":"The Synucleinopathies: Twenty Years on","volume":"7","author":"Goedert","year":"2017","journal-title":"J. Parkinsons. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"22","author":"Pfeiffer","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/mds.27728","article-title":"Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases","volume":"34","author":"Reyero","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/mds.26510","article-title":"Nonmotor features of Parkinson\u2019s disease subtypes","volume":"31","author":"Marras","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/mds.27189","article-title":"Cognition and the Course of Prodromal Parkinson\u2019s Disease Methods Study Description","volume":"32","author":"Weintraub","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/brain\/awm111","article-title":"Evolution of cognitive dysfunction in an incident Parkinson\u2019s disease cohort","volume":"130","author":"Foltynie","year":"2007","journal-title":"Brain"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/mds.23073","article-title":"Association between cognition and function in patients with Parkinson disease with and without dementia","volume":"25","author":"Rosenthal","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.parkreldis.2017.02.005","article-title":"Is fatigue associated with cognitive dysfunction in early Parkinson\u2019s disease?","volume":"37","author":"Kluger","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"39164","DOI":"10.1002\/alz.039164","article-title":"Theory of Mind in mild cognitive impairment: Relationship with the default mode network (DMN)","volume":"16","author":"Michaelian","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"D\u00edez-Cirarda, M., Ojeda, N., Pe\u00f1a, J., Cabrera-Zubizarreta, A., G\u00f3mez-Beldarrain, M.\u00c1., G\u00f3mez-Esteban, J.C., and Ibarretxe-Bilbao, N. (2015). Neuroanatomical correlates of theory of mind deficit in Parkinson\u2019s disease: A multimodal imaging study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142234"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Rektor, I., Sv\u00e1tkov\u00e1, A., Vojt\u00ed\u0161ek, L., Zikmundov\u00e1, I., Van\u00ed\u010dek, J., Kir\u00e1ly, A., and Szab\u00f3, N. (2018). White matter alterations in Parkinson\u2019s disease with normal cognition precede grey matter atrophy. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0187939"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e003976","DOI":"10.1136\/bmjopen-2013-003976","article-title":"White matter integrity and cognition in Parkinson\u2019s disease: A cross-sectional study","volume":"4","author":"Auning","year":"2014","journal-title":"BMJ Open"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbr.2014.12.007","article-title":"Abnormal functional connectivity density in Parkinson\u2019s disease","volume":"280","author":"Zhang","year":"2015","journal-title":"Behav. Brain Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.parkreldis.2015.04.006","article-title":"Parkinsonism and Related Disorders Alterations in the limbic\/paralimbic cortices of Parkinson\u2019s disease patients with hyposmia under resting-state functional MRI by regional homogeneity and functional connectivity analysis","volume":"21","author":"Su","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/psyg.12601","article-title":"Depressive symptoms are associated with worse cognitive prognosis in patients with newly diagnosed idiopathic Parkinson disease","volume":"20","author":"Park","year":"2020","journal-title":"Psychogeriatrics"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/2\/573\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:37:02Z","timestamp":1760121422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/2\/573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["biomedicines11020573"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines11020573","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]}}}